
Develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Director Statistical Programming
London, United Kingdom | full time | Job ID: 11340
About the role:
As Director Statistical Programming you will work alongside the Head/Sr. Director of Statistical Programming as portfolio lead for the Infectious Diseases therapeutic area (e.g., COVID‑19, malaria, monkeypox, HIV, HSV, tuberculosis), implementing a comprehensive statistical programming strategy that maximizes efficiency and quality across the portfolio while ensuring alignment with corporate and regulatory requirements. You will be responsible for overseeing statistical programming deliverables across multiple Infectious Diseases programs and studies (early- and late-stage), including analysis datasets (e.g., SDTM, ADaM), tables, listings, and figures (TLFs), integrated summaries, and other regulatory deliverables and ensure programming strategies are aligned with compound/platform objectives, indication‑specific needs, and regulatory expectations.
Your main responsibilities are:
- Lead the programming contribution to global regulatory submissions (e.g., NDAs, BLAs, MAAs, rolling submissions, emergency use authorizations) for Infectious Diseases assets, ensuring compliance with eCTD requirements, and high‑quality, submission‑ready datasets, TLFs, and documentation (e.g., define.xml, reviewers’ guides)
- Develop and oversee data standards, tools and automation for efficient production and verification of derived datasets (e.g., SDTM and ADaM) and TLFs, including portfolio‑wide solutions for recurrent endpoints (e.g., virology, immunogenicity, efficacy and safety outcomes) in infectious diseases
- Drive the creation, review, and validation of SAS/R programs for clinical data analysis across multiple infectious disease studies and integrated analyses, ensuring compliance with SOPs, regulatory standards, and principles of reproducibility and traceability
- Collaborate cross‑functionally with Clinical Development, Clinical Operations, Pharmacovigilance, Regulatory Affairs, Translational Medicine, and other stakeholders to meet project deliverables and timelines for statistical data analysis and reporting across the Infectious Diseases portfolio and representing statistical programming in clinical study teams, portfolio governance, protocol reviews, and submission readiness meetings
- Guide and collaborate with internal Global Biometric Sciences (GBS) project leads and CRO/FSP staff to ensure alignment with established data, analysis, and quality standards. Provide direction and oversight to external partners delivering programming services for Infectious Diseases projects
- Champion the adoption of advanced analytics, automation tools (e.g., SAS macros, R/Python workflows), and new technologies (e.g., AI/ML, data visualization, decentralized trials, real‑world evidence) within the Infectious Diseases portfolio to enhance programming efficiency and scientific insight
- Identify, define, and monitor programming metrics to assess performance and quality for the Infectious Diseases portfolio. Evaluate existing processes and guidelines, propose enhancements, and implement changes for continuous process improvement and operational excellence
- Participate in, and as appropriate lead, continuous improvement activities and process reengineering initiatives in support of BioNTech’s global clinical and data strategy, contributing Infectious Diseases portfolio perspectives and requirements
- Provide leadership, coaching, and mentoring to programming staff (internal and external) supporting Infectious Diseases, fostering technical excellence, professional development, and a culture of collaboration and innovation
What you have to offer:
- Bachelor’s degree in Statistics, Mathematics, Computer Science or related discipline, advanced degree preferred
- 15+ years (10+ years for advanced degree) experience in a pharmaceutical industry, CRO or another clinical research setting, with a focus on infectious diseases
- Excellent knowledge of statistical programming in SAS including Base, macro, STAT, GRAPH, SQL
- Solid understanding of FDA, EMA, ICH, and global regulations and guidelines
- Solid understanding of industry standards applicable to clinical study data and reporting on clinical trials, including CDISC standards
- Solid understanding of the drug development process from early- to late-stage development and submission
- Expertise in the requirements and technology to support electronic submissions
- Strong project and portfolio management skills
- Strong interpersonal skills in addition to exceptional written and oral communication skills commensurate with the need to work closely with CROs, investigators, consultants, and team members across functions
- Ability to lead cross-functional teams and influence stakeholders in a matrix organization
- Ability to work in a fast-paced and dynamic environment and manage multiple programs simultaneously
- Strong analytical and problem-solving skills, with a focus on innovation, automation, and continuous improvement
Your benefits:
BioNTech is committed to the wellbeing of our team members and offers a variety of benefits in support of our diverse employee base. We offer competitive remuneration packages which is determined by the specific role, location of employment and also the selected candidate’s qualifications and experience.
Note: The availability, eligibility and design of the listed benefits may vary depending on the location. The final requirements for the individual use of our benefits are based on the company's internal policies and applicable law.
How to apply:
Apply now by sending us your application documents including Curriculum Vitae, copy of ID, copies of degree certificates and professional certificates, motivation letter as well as your contact details via our online form.
Please note:
Only applications sent via our online form shall be considered. By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘Hire Right’. You will be informed accordingly by your BioNTech-Recruiter.
We are looking forward receiving your application.
浏览量
0
申请点击
0
Mock Apply
0
收藏
0
相似职位

Supervisor, Health Information and Data
Carnival · Miami, FL, United States, US

Asset & Wealth Management - Quantitative Strategist - Vice President - London
Goldman Sachs · London, Greater London, England, United Kingdom

DATA SCIENTIST LEAD L1
Wipro · Pune, India

Executive Director - Control Manager - Firmwide Chief Analytics Office
JPMorgan Chase · Jersey City, NJ; New York, NY

Associate Director, Biostatistics - Virology
Gilead Sciences · United States - California - Foster City
关于BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
员工数
Mainz that develops immunotherapies
总部位置
$21.7B
企业估值
评价
10条评价
4.0
10条评价
工作生活平衡
2.8
薪酬
3.7
企业文化
4.2
职业发展
3.5
管理层
3.3
78%
推荐率
优点
Innovative and cutting-edge technology projects
Supportive and collaborative team environment
Meaningful and impactful work with strong mission
缺点
Long working hours and high workload
Fast-paced environment can be stressful
High pressure and expectations
薪资范围
38个数据点
L2
L6
Mid/L4
Intern
L3
L4
L5
L2 · Data Scientist L2
0份报告
$53,767
年薪总额
基本工资
$21,507
股票
$26,884
奖金
$5,377
$37,637
$69,897
面试评价
1条评价
难度
3.0
/ 5
时长
14-28周
面试流程
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
常见问题
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
最新动态
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease - WSJ
WSJ
News
·
2w ago
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
News
·
2w ago
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
2w ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3w ago